Monocyte chemoattractant protein 1 gene regulatory region polymorphism and serum levels of monocyte chemoattractant protein 1 in Japanese patients with Kawasaki disease
- 26 September 2001
- journal article
- research article
- Published by Wiley in Arthritis & Rheumatism
- Vol. 44 (9), 2211-2212
- https://doi.org/10.1002/1529-0131(200109)44:9<2211::aid-art375>3.0.co;2-a
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Expression of Monocyte Chemoattractant Protein‐1 in Kawasaki Disease: The Anti‐Inflammatory Effect of Gamma Globulin TherapyScandinavian Journal of Immunology, 2000
- A Novel Polymorphism in the MCP-1 Gene Regulatory Region That Influences MCP-1 ExpressionBiochemical and Biophysical Research Communications, 1999
- Dramatic decrease of circulating levels of monocyte chemoattractant protein-1 in Kawasaki disease after gamma globulin treatmentJournal of Leukocyte Biology, 1999
- Transcriptional Regulation of The Human Monocyte Chemoattractant Protein-1 GeneJournal of Biological Chemistry, 1997
- TNF Regulates the In Vivo Occupancy of Both Distal and Proximal Regulatory Regions of the MCP-1/JE GeneImmunity, 1996
- NF-kappa B and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene.The Journal of Immunology, 1994
- Immunopathology and cytokine detection in the skin lesions of patients with kawasaki diseaseThe Journal of Pediatrics, 1993
- An epidemic of Kawasaki syndrome in HawaiiThe Journal of Pediatrics, 1982